Does chlorthalidone therapy improve blood-pressure control at 12 weeks in patients with advanced chronic kidney disease and poorly controlled hypertension?
Chlorthalidone effectively improves blood pressure control in patients with advanced chronic kidney disease and poorly controlled hypertension.
Among patients with advanced chronic kidney disease and poorly controlled hypertension, chlorthalidone therapy improved blood-pressure control at 12 weeks as compared with placebo. (Funded by the National Heart, Lung, and Blood Institute and the Indiana Institute of Medical Research; CLICK ClinicalTrials.gov number, NCT02841280.).
Agarwal et al. (Fri,) studied this question.